Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 12.35
-0.15 (-1.20%)
Jul 24, 2026, 1:11 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 87.18 million as of July 24, 2026. Its market cap has decreased by -61.65% in one year.
Market Cap
87.18M
Enterprise Value
70.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.35
ChartMarket Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 87.18M, an increase of 73.63%. That is a compound annual growth rate of 6.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 87.18M | -37.63% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 142.35M |
| Biovica International AB | 141.58M |
| Alzinova AB | 141.44M |
| NextCell Pharma AB | 128.92M |
| Alligator Bioscience AB | 121.85M |
| OncoZenge AB | 102.41M |
| Spago Nanomedical AB | 76.74M |
| AcouSort AB | 75.56M |